Hernández, L.E.; Vega Avalos, J.H.; Zuñiga, L.Y.; Sánchez-Parada, M.G.; González Santiago, A.E.; Román Pintos, L.M.; Castañeda Arellano, R.; Hernández Ortega, L.D.; Mercado Sesma, A.R.; Orozco-Luna, F.D.J.; Baptista-Rosas, R.C. Mitochondrial Control Region Variants Related to Breast Cancer. Preprints2022, 2022080337. https://doi.org/10.20944/preprints202208.0337.v1
Hernández, L.E., Vega Avalos, J.H., Zuñiga, L.Y., Sánchez-Parada, M.G., González Santiago, A.E., Román Pintos, L.M., Castañeda Arellano, R., Hernández Ortega, L.D., Mercado Sesma, A.R., Orozco-Luna, F.D.J., & Baptista-Rosas, R.C. (2022). Mitochondrial Control Region Variants Related to Breast Cancer. Preprints. https://doi.org/10.20944/preprints202208.0337.v1
Hernández, L.E., Felipe de Jesús Orozco-Luna and Raul C. Baptista-Rosas. 2022 "Mitochondrial Control Region Variants Related to Breast Cancer" Preprints. https://doi.org/10.20944/preprints202208.0337.v1
Breast cancer has an important incidence in the worldwide female population. Although alterations in the mitochondrial genome probably play an important role in carcinogenesis, the actual evidence is ambiguous and inconclusive. The purpose of the present work was to explore mitochondrial sequences of clinical cases with breast cancer from different origins and determine the polymorphisms associated. The search for complete and partial mtDNA sequences obtained from breast cancer patients and controls was performed in NCBI Genbank database. We identified 124 mtDNA sequences associated to breast cancer cases of which 86 were complete and 38 partial sequences. Of these 86 complete sequences, 52 belong to patients with a confirmed diagnosis of breast cancer and 34 sequences were obtained from healthy mammary tissue of the same patients used as controls. From mtDNA analysis, two polymorphisms with significative statistical differences were found in D130 in sequences analyzed: m.310del (rs869289246) in 34.6% (27/78) breast cancer cases and 61.7% (21/34) of controls; and m.315dup (rs369786048) in 60.2% (47/78) of breast cancer cases and 38.2% (13/34) of controls. Also, the variant m.16519T>C (rs3937033) was found in 59% of control sequences and 52% of breast cancer sequences with a significant statistical difference. Polymorphic changes are evolutionarily related to haplogroup H of Indo-European and Euro Asiatic origins, however, were found in all non-European sequences with breast cancer.
breast cancer; polymorphism; mitochondrial genomics; D310
Biology and Life Sciences, Biochemistry and Molecular Biology
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.